AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Aurora Cannabis Inc (NASDAQ:ACB)
3.38 USD
-0.130 3.704%Sponsored Reports
Loading...
| Previous Close (in USD) | 3.51 |
|---|---|
| Change | -0.130 3.704% |
| 52 W H/L (in USD) | 6.665/3.070 |
| EBITDA (in USD) | -32.735M |
| PE Ratio | -- |
| Volume | 929409 |
| Diluted Eps TTM | -1.09 |
| Total Assets (in USD) | 847.766M |
|---|---|
| Total Liabilities (in USD) | 242.672M |
| Revenue TTM (in USD) | 373.118M |
| Cash (in USD) | 184.263M |
| Market Cap (in USD) | 210.491 M |
| Revenue Per Share TTM | 6.644 |
| Gross Profit TTM (in USD) | 134.425M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Miguel Martin | CEO & Director | 1972 |
| 2. | Mr. Glen Ibbott | Chief Financial Officer | NA |
| 3. | Mr. Alex Miller | Exec. VP of Operations & Supply Chain | NA |
| 4. | Ms. Lori Schick | Exec. VP of HR | NA |
| 5. | Mr. Andre Jerome | Exec. VP of Global Bus. Devel. | NA |
| 6. | Ananth Krishnan | VP of Capital Markets & Investor Relations | NA |
| 7. | Mr. Nathalie Clark | Exec. VP, Gen. Counsel & Corp. Sec. | NA |
| 8. | Michelle Lefler | VP of Communications & PR | NA |
| 9. | Mr. Carey Squires | Exec. VP of Corp. Devel. & Strategy | NA |
| 10. | Mr. John Barnet | Chief Cultivator | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
-0.080 0.101% | 79.54 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
-1.130 3.482% | 32.09 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
-5.400 3.299% | 158.31 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
GALDY
GALDERMA GROUP AG |
-0.130 0.320% | 40.64 | 74.210 | 41.667 | 8.636 | 5.553 | 9.151 | 42.220 |
Income Statement
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 31-03-2023 | 30-06-2022 | 31-03-2022 |
|---|---|---|---|---|---|
| Income Before Tax | 20.382M | -59.599M | -295.419M | -1720.12M | -1720.12M |
| Minority Interest | - | - | 2.062M | 0.355M | 0.355M |
| Net Income | 1.591M | -69.326M | -265.329M | -1717.624M | -1717.624M |
| Selling General Administrative | 110.187M | 104.939M | 68.219M | 126.969M | 126.969M |
| Gross Profit | 187.607M | 131.46M | -64.36M | 21.225M | 21.225M |
| Reconciled Depreciation | 22.547M | 33.071M | 65.23M | 93.66M | 93.66M |
| Ebit | 28.802M | -12.597M | -254.318M | -236.749M | -236.749M |
| Ebitda | 51.349M | 20.474M | -210.745M | -143.089M | -143.089M |
| Depreciation And Amortization | 22.547M | 33.071M | 43.573M | 93.66M | 93.66M |
| Operating Income | 4.948M | -46.453M | -254.318M | -231.449M | -231.449M |
| Other Operating Expenses | 338.345M | 297.36M | 487.608M | 440.714M | 440.714M |
| Interest Expense | 8.42M | 14.186M | 39.461M | 71.813M | 71.813M |
| Tax Provision | 4.619M | -0.554M | -13.64M | -2.141M | -2.141M |
| Interest Income | 11.505M | 12.813M | 9.876M | 4.507M | 4.507M |
| Net Interest Income | 3.085M | -1.373M | -51.525M | -67.306M | -67.306M |
| Income Tax Expense | 4.619M | -0.554M | -20.316M | -2.141M | -2.141M |
| Total Revenue | 343.293M | 270.281M | 233.29M | 221.339M | 221.339M |
| Total Operating Expenses | 182.659M | 158.539M | 189.958M | 240.6M | 240.6M |
| Cost Of Revenue | 155.686M | 138.821M | 297.65M | 200.114M | 200.114M |
| Total Other Income Expense Net | 15.434M | -31.147M | -41.101M | -1433.439M | -1433.439M |
| Net Income From Continuing Ops | 15.763M | -59.045M | -1750.022M | -1717.979M | -1717.979M |
| Net Income Applicable To Common Shares | - | - | - | -1717.624M | -1717.624M |
Balance Sheet
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 30-06-2023 | 31-03-2023 | 30-06-2022 |
|---|---|---|---|---|---|
| Total Assets | 847.766M | 838.673M | 926.322M | 926.322M | 1084.356M |
| Intangible Assets | 44.903M | 40.85M | 61.403M | 61.403M | 70.696M |
| Other Current Assets | 10.82M | 9.402M | 8.918M | 8.918M | 6.539M |
| Total Liab | 242.672M | 236.803M | 409.185M | 409.185M | 422.002M |
| Total Stockholder Equity | 563.912M | 559.773M | 486.076M | 486.076M | 661.843M |
| Other Current Liab | 44.844M | 21.019M | 71.069M | 48.966M | 94.516M |
| Common Stock | 6950.979M | 6971.416M | 6841.234M | 6841.234M | 6754.626M |
| Capital Stock | 6991.154M | 6971.416M | - | - | 6754.626M |
| Retained Earnings | -6331.153M | -6367.936M | -6296.833M | -6296.833M | -6038.275M |
| Good Will | 43.619M | 43.18M | 18.715M | 18.715M | 0M |
| Other Assets | - | - | - | - | 33.867M |
| Cash | 184.263M | 113.439M | 300.842M | 300.842M | 437.807M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 110.226M | 124.62M | 242.305M | 242.305M | 145.228M |
| Current Deferred Revenue | 1.068M | 1.687M | 1.739M | 1.739M | 3.85M |
| Net Debt | -80.281M | -8.648M | -73.32M | -73.32M | -168.316M |
| Short Term Debt | 26.739M | 57.217M | 147.555M | 147.555M | 33.004M |
| Short Long Term Debt | 21.513M | 52.361M | - | - | 26.854M |
| Short Long Term Debt Total | 103.982M | 104.791M | 227.522M | 227.522M | 269.491M |
| Other Stockholder Equity | - | - | -0M | -0M | -54.508M |
| Property Plant Equipment | - | - | - | - | 230.304M |
| Total Current Assets | 475.579M | 426.605M | 479.927M | 479.927M | 745.121M |
| Long Term Investments | - | - | - | - | 1.207M |
| Short Term Investments | 0.551M | 4.036M | - | - | 1.331M |
| Net Receivables | 42.226M | 45.411M | 41.345M | 41.345M | 47.052M |
| Long Term Debt | 40.194M | 4.898M | - | - | 199.65M |
| Inventory | 237.719M | 186.376M | 128.822M | 128.822M | 139.925M |
| Accounts Payable | 27.461M | 20.325M | 21.942M | 21.942M | 13.858M |
| Accumulated Other Comprehensive Income | -55.915M | -43.707M | -58.325M | -58.325M | -54.508M |
| Non Currrent Assets Other | 7.678M | 12.028M | 14.063M | 14.063M | 33.867M |
| Non Current Assets Total | 372.187M | 412.068M | 446.395M | 446.395M | 339.235M |
| Capital Lease Obligations | 42.876M | 47.532M | - | - | 42.987M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-03-2025 | 31-03-2024 | 31-03-2023 | 30-06-2022 | 31-03-2022 |
|---|---|---|---|---|---|
| Investments | -14.327M | -5.487M | -54.674M | -36.6M | -36.6M |
| Total Cashflows From Investing Activities | -14.327M | - | - | -36.6M | -36.6M |
| Total Cash From Financing Activities | -0.116M | -47.923M | -56.478M | 147.779M | 147.779M |
| Net Income | 15.763M | -59.045M | -265.329M | -1717.979M | -1717.979M |
| Change In Cash | 1.826M | -121.503M | -140.009M | 16.35M | 16.35M |
| Begin Period Cash Flow | 136.095M | 234.942M | 440.851M | 421.457M | 421.457M |
| End Period Cash Flow | 137.921M | 113.439M | 300.842M | 437.807M | 437.807M |
| Total Cash From Operating Activities | 16.005M | -68.508M | -115.821M | -109.838M | -109.838M |
| Depreciation | 22.547M | 33.071M | 43.573M | 93.66M | 93.66M |
| Other Cashflows From Investing Activities | -0.956M | - | - | -0.185M | -0.185M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -15.049M | 3.615M | 49.028M | 21.068M | 21.068M |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | -0.131M | -5.487M | -95.208M | -31.578M | -31.578M |
| Capital Expenditures | 18.859M | 16.956M | 12.132M | 32.213M | 32.213M |
| Change In Working Capital | 10.21M | -15.627M | -25.116M | 49.95M | 49.95M |
| Other Non Cash Items | -40.849M | -70.841M | 190.109M | 1452.967M | 1452.967M |
| Free Cash Flow | -2.854M | -85.464M | -127.953M | -142.051M | -142.051M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ETFMG Alternative Harvest ETF | 2 months ago | 1249667 |
| 2. | Global X Marijuana Life Sciences ETF | 2 months ago | 474498 |
| 3. | AdvisorShares Pure Cannabis ETF | 2 months ago | 171110 |
| 4. | Cinvest A&A International Investment FI | 3 months ago | 141536 |
| 5. | TD Canadian Equity Index ETF | 2 months ago | 66819 |
| 6. | Mackenzie Canadian Equity ETF | 2 months ago | 58062 |
| 7. | State Street® SPDR® S&P® Intl Sm Cp ETF | 2 months ago | 52421 |
| 8. | iShares S&P/TSX Small Cap ETF | 2 months ago | 44660 |
| 9. | DFA Canadian Vector Equity Class F | 4 months ago | 42628 |
| 10. | DFA Canadian Core Equity Class F | 4 months ago | 41700 |
| 11. | Dimensional International Cr Eq Mkt ETF | 2 months ago | 34720 |
| 12. | Fidelity Nasdaq Composite Index | 3 months ago | 32619 |
| 13. | Dimensional International Core Eq 2 ETF | 2 months ago | 23135 |
| 14. | TD Canadian Index - I | 5 months ago | 21100 |
| 15. | CANSOUL Fonds Hanf Aktien Global EUR C | 3 months ago | 20000 |
| 16. | Dimensional International Small Cap ETF | 2 months ago | 19342 |
| 17. | Dimensional World ex US Core Eq 2 ETF | 2 months ago | 17523 |
| 18. | Desjardins Canadian Equity Index ETF | 2 months ago | 17285 |
| 19. | DFA International Core Equity 2 I | 3 months ago | 14401 |
| 20. | Scotia Canadian Equity Index A | 5 months ago | 10821 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Tidal Investments LLC. | 5 months ago | 1148723 |
| 2. | The Goldman Sachs Group Inc | 5 months ago | 993131 |
| 3. | Two Sigma Investments LLC | 5 months ago | 771142 |
| 4. | Renaissance Technologies Corp | 5 months ago | 770244 |
| 5. | Jane Street Group LLC | 5 months ago | 165349 |
| 6. | Royal Bank of Canada | 8 months ago | 160481 |
| 7. | Trexquant Investment LP | 5 months ago | 139853 |
| 8. | Point72 Asset Management, L.P. | 5 months ago | 91898 |
| 9. | OZ Management LLC | 5 months ago | 84500 |
| 10. | TD Asset Management Inc | 5 months ago | 78255 |
| 11. | D. E. Shaw & Co LP | 5 months ago | 76058 |
| 12. | Group One Trading, LP | 5 months ago | 74032 |
| 13. | Citigroup Inc | 8 months ago | 71930 |
| 14. | SIG North Trading, ULC | 5 months ago | 61734 |
| 15. | Morgan Stanley - Brokerage Accounts | 8 months ago | 308046 |
| 16. | Citadel Advisors Llc | 5 months ago | 249173 |
| 17. | Two Sigma Advisers, LLC | 5 months ago | 227653 |
| 18. | Millennium Management LLC | 5 months ago | 208150 |
| 19. | AdvisorShares Investments, LLC | 5 months ago | 185270 |
| 20. | UBS Group AG | 8 months ago | 184190 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...